Heavy Grief Nearly Doubles Bereaved's Risk Of Early Death
By Dennis Thompson HealthDay Reporter

FRIDAY, July 25, 2025 — People intensely grieving a loved one are nearly twice as likely to die within a decade of their loss, a new study says.
Those whose grief remained persistently high in the first years following a loss have 88% increased odds of dying within 10 years of their loved one’s passing, according to results published in Frontiers in Public Health.
They also are nearly three times more likely to receive mental health care like talk therapy, greater than five times more likely to be prescribed antidepressants, and more than twice as likely to receive sedatives or anxiety drugs, results show.
“This is the first study to investigate the long-term use of health care and patterns of mortality over a decade after bereavement in a large-scale cohort,” lead researcher Mette Kjaergaard Nielsen said in a news release. She’s a postdoctoral researcher at the Research Unit for General Practice in Aarhus, Denmark.
For the new study, researchers recruited more than 1,700 bereaved men and women in Denmark with an average age of 62. Among them, 66% had lost their partner, 27% a parent and 7% another loved one.
The study participants were given a questionnaire that assessed their levels of grief during the first three years after losing a loved one.
About 6% of participants had levels of grief that remained high despite the passing of time, and 38% had persistently low levels, results show. Another 47% experienced high or moderate grief at first that ebbed over time.
Following the people out for 10 years, researchers found those with heavy and unrelenting grief were more likely to die early and to need some sort of psychiatric help.
Researchers can’t say exactly why unrelenting grief might increase a person’s risk of early death.
“We have previously found a connection between high grief symptom levels and higher rates of cardiovascular disease, mental health problems and even suicide,” Nielsen said. “But the association with mortality should be further investigated.”
However, there’s a chance doctors might identify people at risk of heavy and prolonged grief, since these folks were more likely to have prescriptions for psychiatric conditions even before their loss, researchers said.
"The 'high grief' group had lower education on average, and their more frequent use of medication before bereavement suggested that they had signs of mental vulnerability, which may cause greater distress following the death of a loved one," Nielsen said.
She said a doctor could look for previous signs of depression or other severe mental health conditions.
“They can then offer these patients tailored follow-up in general practice, or refer them to a private-practice psychologist or secondary care," Nielsen said. "The (doctor) may also suggest a bereavement follow-up appointment focusing on mental health.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-07-26 00:00
Read more

- Men With Hidradenitis Suppurativa Perceive Better Physician Communication
- Study Compares Benefits, Harms of Treatments for Chronic Hives
- Killer Whales Show a Softer Side, Sharing Food With People
- Takeda Announces U.S. FDA Approval of Gammagard Liquid ERC, the Only Ready-to-Use Liquid Immunoglobulin Therapy with Low Immunoglobulin A (IgA) Content
- U.S. Hospitals Face Shortages in Essential Staff Due to Foreign Residency Visa Delays
- Increased Liver Enzyme Levels Seen With Use of Cannabidiol in Adults
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions